Top Stories
-
Experts on convalescent plasma discuss why randomized clinical trials of the treatment in COVID-19 patients are more important than ever.
Topic
-
Columbia researchers have uncovered an array of new genes that cause stillbirth, significantly increasing the understanding of the genetic foundations of a common, but little studied, condition.
Topic
-
New genetic and patient analyses suggest severe COVID is linked to overactive complement, one of the immune system’s oldest branches, and excess blood clotting.
Topic
-
Columbia's Irving Institute for Clinical and Translational Research selected five new Herbert and Florence Irving Scholars to receive funding for the next three years to support their research.
Topic
Latest News
- November 14, 2018
With a genome that’s regularly broken into 225,000 pieces and reassembled, a pond protist may be the perfect creature to teach us how genomic stability—often lost in cancer—is maintained.
Topic
- October 11, 2018
A new study shows how certain cells ‘cheat’ during cell competition to eliminate their neighbors and take over tissues; the findings could point toward new strategies for treating cancer.
Topic
- October 9, 2018
The discovery of genes that control eye growth gives researchers critical information in the search for drugs that can prevent nearsightedness, the world’s most common eye disorder.
Topic
- October 5, 2018
Community health workers may be able to help youths with sickle cell disease live healthier lives, according to a new study from Columbia's School of Nursing and Department of Pediatrics.
Topic
- September 25, 2018
Insomnia accounts for a significantly greater loss of quality of life at the population level than arthritis, obesity, or depressive disorders, a new study from Columbia Psychiatry has found.
Topic
- September 21, 2018
Columbia University awards the 2018 Louisa Gross Horwitz Prize to Pierre Chambon, Ronald M. Evans, and Bert W. O’Malley for their research—spanning over 50 years—decoding how steroid hormones and nuclear receptors regulate cell function.
- September 18, 2018
A new anti-inflammatory drug may offer hope for people with a progressive form of MS. In a phase 2 trial, the drug slowed brain atrophy in people with the disease.
Topic
- September 17, 2018
A new study finds that regulatory gene variants can affect the severity of a genetic disease among people with the same protein-coding mutation.
Topic
- September 6, 2018
A CUIMC study found that during the 2016 presidential election Republicans made gains in counties with more "deaths of despair."
Topic
- September 5, 2018
A new study suggests that, among older adults, cognitive performance changes with the seasons and peaks in late summer.
Topic
